Cargando…
Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
Diabetes mellitus (DM), a chronic metabolic disorder characterized by high blood glucose, not only poses a serious threat to human life and health, but also places an economic burden on society. Currently available antidiabetic pharmacological agents have some adverse effects, which have stimulated...
Autores principales: | Wang, Xuekun, Li, Xu, Wei, Shiting, Wang, Min, Xu, Yao, Hu, Weidi, Gao, Zhenzhen, Liu, Renmin, Wang, Shiben, Ji, Guoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781217/ https://www.ncbi.nlm.nih.gov/pubmed/36558150 http://dx.doi.org/10.3390/molecules27249018 |
Ejemplares similares
-
Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes
por: Ji, Guoxia, et al.
Publicado: (2021) -
Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022) -
Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120
por: Ma, Siyue, et al.
Publicado: (2022) -
Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors
por: Mohan, Sellappan, et al.
Publicado: (2022) -
GPR120/FFAR4 Pharmacology:
Focus on Agonists in Type
2 Diabetes Mellitus Drug Discovery
por: Carullo, Gabriele, et al.
Publicado: (2021)